BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9448024)

  • 41. [27-year-old patient with asymptomatic cholestasis and liver tumor].
    Möllers M; Gladisch R; Heine M; Georgi M; Heene DL
    Internist (Berl); 1996 Sep; 37(9):931-5. PubMed ID: 8964688
    [No Abstract]   [Full Text] [Related]  

  • 42. [Cholangiocarcinomas developing on multiple bile duct hamartomas syndrome].
    Droy L; Sagan C; Paineau J; Gournay J; Mosnier JF
    Ann Pathol; 2009 Feb; 29(1):24-7. PubMed ID: 19233090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extrahepatic cholangiocarcinoma: current surgical strategy.
    Boutros C; Somasundar P; Espat NJ
    Surg Oncol Clin N Am; 2009 Apr; 18(2):269-88, viii. PubMed ID: 19306812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.
    Baskin-Bey ES; Moreno Luna LE; Gores GJ
    J Hepatol; 2006 Oct; 45(4):476-9. PubMed ID: 16901574
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of congenital dilatation of the bile ducts. Apropos of 3 cases].
    Berger A; Roger V; Wind P; Chevallier JM; Cugnenc PH
    J Chir (Paris); 1997 Dec; 134(7-8):305-10. PubMed ID: 9772995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
    Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
    Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholangiocarcinoma arising in von Meyenburg complexes.
    Kim HK; Jin SY
    Korean J Hepatol; 2011 Jun; 17(2):161-4. PubMed ID: 21757989
    [No Abstract]   [Full Text] [Related]  

  • 48. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
    Cheifetz RE; Davis NL; Owen DA
    Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis.
    Charbel H; Al-Kawas FH
    Curr Gastroenterol Rep; 2011 Apr; 13(2):182-7. PubMed ID: 21271364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The extrahepatic bile duct lesions in end-stage primary sclerosing cholangitis.
    Katabi N; Albores-Saavedra J
    Am J Surg Pathol; 2003 Mar; 27(3):349-55. PubMed ID: 12604891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Etiological classification and treatment strategies for secondary bile duct dilatation.
    Lv Y; Liu N; Wu H; Li Z
    Exp Biol Med (Maywood); 2021 Feb; 246(3):281-285. PubMed ID: 33167690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hilar cholangiocarcinoma: pathology and tumor biology.
    Kuang D; Wang GP
    Front Med China; 2010 Dec; 4(4):371-7. PubMed ID: 21110142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multifocal cholangiocarcinoma in an explanted liver allograft following retransplant for recurrent primary sclerosing cholangitis.
    Law R; Yerian L; Miller C; Dasarathy S
    Trop Gastroenterol; 2010; 31(4):317-20. PubMed ID: 21568150
    [No Abstract]   [Full Text] [Related]  

  • 56. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
    Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
    J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic hilar inflammatory pseudotumor mimicking cholangiocarcinoma with cholangitis and phlebitis--a variant of primary sclerosing cholangitis?
    Nonomura A; Minato H; Shimizu K; Kadoya M; Matsui O
    Pathol Res Pract; 1997; 193(7):519-25; discussion 526. PubMed ID: 9342759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A case of segmental primary sclerosing cholangitis associated with early cholangiocarcinoma--a review of the Japanese literature].
    Kaieda M; Hamada N; Ishizaki N; Nakamura N; Kadono J; Fukueda M; Sakata R; Higashi M; Kitajima S; Yonezawa A
    Nihon Shokakibyo Gakkai Zasshi; 2002 Mar; 99(3):307-12. PubMed ID: 11925870
    [No Abstract]   [Full Text] [Related]  

  • 59. [The vascular and ductal systems of the liver in portal and biliary hypertension].
    Tsaĭ GE; Komarov IA; Dubovikov GV
    Sov Med; 1990; (12):80-2. PubMed ID: 2097769
    [No Abstract]   [Full Text] [Related]  

  • 60. Peribiliary cysts can mimic Caroli's disease: a case report.
    Fusai G; Tucker O; Nik Sulaiman NM; Karani J; Rela M; Portmann B
    Int J Surg Pathol; 2005 Oct; 13(4):379-82. PubMed ID: 16273200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.